Kube, D; Hua, TD; Klöss, M et al.
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.Genes Immun. Bd. 8. H. 2. 2007 S. 164-7
Ziesche, E; Bachmann, M; Kleinert, H et al.
The Interleukin-22/STAT3 Pathway Potentiates Expression of Inducible Nitric-oxide Synthase in Human Colon Carcinoma Cells.J Biol Chem. Bd. 282. H. 22. 2007 S. 16006-15
Bros, M; Boissel, JP; Godtel-Armbrust, U et al.
The untranslated region of exon 2 of the human neuronal nitric oxide synthase (NOS1) gene exerts regulatory activity.Gene. Bd. 405. H. 1-2. 2007 S. 36-46
Steinkamp-Fenske, K; Bollinger, L; Völler, N et al.
Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells.Atherosclerosis. Bd. 195. H. 1. 2007 S. e104-11
Gödtel-Armbrust, U; Metzger, A; Kroll, U et al.
Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.Naunyn Schmiedebergs Arch Pharmacol. Bd. 375. H. 6. 2007 S. 377-82
Rotmann, A; Vekony, N; Gassner, D et al.
Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane.Biochem J. Bd. 395. H. 1. 2006 S. 117-23
Wojnowski, L
ADHD drugs and cardiovascular riskN Engl J Med. Bd. 354. H. 21. 2006 S. 2296-8; author reply 2296-8
Niemi, M; Arnold, KA; Backman, JT et al.
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.Pharmacogenet Genomics. Bd. 16. H. 11. 2006 S. 801-8
Wojnowski, L; Kamdem, LK
Clinical implications of CYP3A polymorphisms.Expert Opin Drug Metab Toxicol. Bd. 2. H. 2. 2006 S. 171-82
Pommerening, K; Muscholl, M
Datenschutz und DatensicherheitB. Herbig, A. Büssing (Hrsg). Informations- und Kommunikationstechnologien im Krankenhaus. Stuttgart: Schattauer Verlag 2006